Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.11 EUR
1.85 M EUR
13.08 M EUR
4.75 M
About BIOHIT OYJ B
Sector
Industry
CEO
Jussi Hahtela
Website
Headquarters
Helsinki
Founded
1988
ISIN
FI0009005482
FIGI
BBG000BXNJ89
Biohit Oyj engages in the development, manufacture, and market of diagnostic tests and analysis systems. It also offers acetaldehyde binding products, monoclonal antibodies, and instruments. The company was founded by Osmo Suovaniemi in 1988 and is headquartered in Helsinki, Finland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of BIOBV is 2.37 EUR — it has decreased by −2.87% in the past 24 hours. Watch BIOHIT OYJ B stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXHEX exchange BIOHIT OYJ B stocks are traded under the ticker BIOBV.
BIOBV stock has fallen by −1.25% compared to the previous week, the month change is a −0.42% fall, over the last year BIOHIT OYJ B has showed a 22.48% increase.
We've gathered analysts' opinions on BIOHIT OYJ B future price: according to them, BIOBV price has a max estimate of 2.70 EUR and a min estimate of 2.70 EUR. Watch BIOBV chart and read a more detailed BIOHIT OYJ B stock forecast: see what analysts think of BIOHIT OYJ B and suggest that you do with its stocks.
BIOBV reached its all-time high on Feb 9, 2000 with the price of 13.50 EUR, and its all-time low was 0.91 EUR and was reached on Oct 31, 2008. View more price dynamics on BIOBV chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BIOBV stock is 5.49% volatile and has beta coefficient of 0.10. Track BIOHIT OYJ B stock price on the chart and check out the list of the most volatile stocks — is BIOHIT OYJ B there?
Today BIOHIT OYJ B has the market capitalization of 37.04 M, it has increased by 3.40% over the last week.
Yes, you can track BIOHIT OYJ B financials in yearly and quarterly reports right on TradingView.
BIOHIT OYJ B is going to release the next earnings report on Feb 12, 2025. Keep track of upcoming events with our Earnings Calendar.
BIOBV earnings for the last half-year are 0.08 EUR per share, whereas the estimation was 0.09 EUR, resulting in a −8.10% surprise. The estimated earnings for the next half-year are 0.04 EUR per share. See more details about BIOHIT OYJ B earnings.
BIOHIT OYJ B revenue for the last half-year amounts to 7.43 M EUR, despite the estimated figure of 7.60 M EUR. In the next half-year revenue is expected to reach 7.69 M EUR.
BIOBV net income for the last half-year is 1.20 M EUR, while the previous report showed 500.00 K EUR of net income which accounts for 140.00% change. Track more BIOHIT OYJ B financial stats to get the full picture.
No, BIOBV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 13, 2024, the company has 46.00 employees. See our rating of the largest employees — is BIOHIT OYJ B on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BIOHIT OYJ B EBITDA is 2.10 M EUR, and current EBITDA margin is 16.86%. See more stats in BIOHIT OYJ B financial statements.
Like other stocks, BIOBV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BIOHIT OYJ B stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BIOHIT OYJ B technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BIOHIT OYJ B stock shows the neutral signal. See more of BIOHIT OYJ B technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.